Synthetic Lipolytic Domain Characterization Ng et al., Hormone Research (2000) Ng and colleagues conducted foundational characterization studies of the AOD-9604 synthetic lipolytic domain using a combination of in vitro adipocyte assays and in vivo obese Zucker rat models
We offer nutritional counselling to help you adjust your diet to best suit your body
Clinical Applications: Chronic viral infections (hepatitis B/C, Lyme disease) Immune deficiency states Cancer immunotherapy support Autoimmune condition modulation Recovery from severe illness or surgery Dosing: Typically 1.6-3.2 mg subcutaneously, 2-3 times per week for immune support, or daily for acute conditions
investigators considered them unrelated, but no long-term oncology safety data exists)
You follow post-treatment care instructions carefully
Side effects are comparable, though AOD 9604 has more clinical data supporting its safety profile